ptTheragnostic Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 2

ptTheragnostic General Information

Description

Provider of biotechnology services. The company focuses on the development of genomics-based personalized analysis for radiation sensitivity to optimize radiation treatment for cancer as well as chronic disease risk prediction.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Parent Company
DNAmito
Primary Office
  • Maastricht
  • Netherlands
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

ptTheragnostic Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore ptTheragnostic‘s full profile, request access.

Request a free trial

ptTheragnostic Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Provider of biotechnology services. The company focuses on the development of genomics-based personalized analysis for r
Biotechnology
Maastricht, Netherlands
000000&0

00000000

commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu
0000 000000000
Louisville, KY
000.00
0000000000 0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ptTheragnostic Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
00000000 000000 00 Venture Capital-Backed Louisville, KY 000.00 0000000000 0 000.00
You’re viewing 1 of 1 competitors. Get the full list »